OPSYNVI® logo

This site is intended for
U.S. healthcare professionals

I Am a Patient or Caregiver
I Am a Healthcare Professional
  • Other Products
    OPSUMIT® logo

    OPSUMIT® (macitentan)

    Please see full Prescribing Information, including BOXED WARNING, for OPSUMIT®.

    UPTRAVI® logo

    UPTRAVI® (selexipag)

    Please see full Prescribing Information for UPTRAVI®.

    Tracleer logo

    TRACLEER® (bosentan)

    Please see full Prescribing Information, including BOXED WARNING, for TRACLEER®.

    Veletri logo

    VELETRI® (epoprostenol) for Injection

    Please see full Prescribing Information for VELETRI®.

  • For U.S. Healthcare Professionals
  • Open menu
    • Medical Information
    • Important Safety Information
    • Prescribing Information
    • For Patients
  • OPSYNVI® logo
  • Home
  • About PAH
    What is PAH?
    Delays in PAH Diagnosis
  • Combination Therapy
  • A DUE Trial
    Study Design
    Reduction in PVR
  • Safety
    Safety And Tolerability
  • Dosing and Administration
  • Resources and Support
    Coverage and Access
    Support Programs
    Downloadable Resources
    Patients Profiles
  • Other Products

    OPSUMIT® (macitentan)

    Please see full Prescribing Information, including BOXED WARNING, for OPSUMIT®.

    UPTRAVI® (selexipag)

    Please see full Prescribing Information for UPTRAVI®.

    TRACLEER® (bosentan)

    Please see full Prescribing Information, including BOXED WARNING, for TRACLEER®.

    VELETRI® (epoprostenol) for Injection

    Please see full Prescribing Information for VELETRI®.
  • Questions
    Request a Medical Science Liaison (MSL)
    Contact your MSLDark blue arrow
  • Download
    Enrollment Form
    Download icon
  • Enrollment and Prescription
    Download icon
Site Map
HomePage
About PAH
Combination Therapy
A DUE Trial
Safety
Dosing and Administration
Resources and Support
Request a Medical
Science Liaison (MSL)Contact your MSL Dark blue arrow